
Markets & Stocks
London-Listed Medical Cannabis Firm Purchases Israeli Clinical Trial Specialist
LONDON Stock Exchange-listed MGC Pharmaceuticals is to acquire Israeli clinical trial specialist MediCaNL for £3.3m (A$6m) in a share-based transaction. On



